Ensysce Biosciences (ENSC) Revenue & Revenue Breakdown
Ensysce Biosciences Revenue Highlights
Latest Revenue (Y)
$2.23M
Ensysce Biosciences Revenue by Period
Ensysce Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.23M | -11.61% |
| 2022-12-31 | $2.52M | -28.54% |
| 2021-12-31 | $3.53M | -10.18% |
| 2020-12-31 | $3.93M | 122.86% |
| 2019-12-31 | $1.76M | 100.00% |
| 2018-12-31 | - | - |
Ensysce Biosciences generated $2.23M in revenue during NA 2023, up -11.61% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Ensysce Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $305.72K | -40.64% |
| 2023-12-31 | $515.03K | 18.29% |
| 2023-09-30 | $435.38K | -11.23% |
| 2023-06-30 | $490.47K | -37.89% |
| 2023-03-31 | $789.63K | -44.91% |
| 2022-12-31 | $1.43M | 413.14% |
| 2022-09-30 | $279.35K | 34.65% |
| 2022-06-30 | $207.47K | -65.60% |
| 2022-03-31 | $603.10K | -63.12% |
| 2021-12-31 | $1.64M | 36.18% |
| 2021-09-30 | $1.20M | 170.14% |
| 2021-06-30 | $444.52K | 77.40% |
| 2021-03-31 | $250.58K | -39.84% |
| 2020-12-31 | $416.49K | -49.68% |
| 2020-09-30 | $827.64K | -54.64% |
| 2020-06-30 | $1.82M | 111.58% |
| 2020-03-31 | $862.40K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Ensysce Biosciences generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Ensysce Biosciences Revenue Breakdown
Ensysce Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 |
|---|---|---|
| M P A R | - | $2.01M |
Quarterly Revenue by Product
| Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 |
|---|---|---|---|---|---|
| MPAR | $437.26K | $481.28K | - | - | - |
| M P A R | - | - | $1.30M | - | - |
| OUD | - | - | - | $73.06K | $207.47K |
Ensysce Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: MPAR (100.00%).
Ensysce Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ENSC | Ensysce Biosciences | $2.23M | - |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| PXMD | PaxMedica | - | - |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ATNF | 180 Life Sciences | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ALLR | Allarity Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| CDIO | Cardio Diagnostics | - | $7.87K |
| BWV | Onconetix | - | - |
ENSC Revenue FAQ
What is Ensysce Biosciences’s yearly revenue?
Ensysce Biosciences's yearly revenue for 2023 was $2.23M, representing a decrease of -11.61% compared to 2022. The company's yearly revenue for 2022 was $2.52M, representing a decrease of -28.54% compared to 2021. ENSC's yearly revenue for 2021 was $3.53M, representing a decrease of -10.18% compared to 2020.
What is Ensysce Biosciences’s quarterly revenue?
Ensysce Biosciences's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $305.72K, a -40.64% decrease from the previous quarter (Q4 2023), and a -61.28% decrease year-over-year (Q1 2023). ENSC's quarterly revenue for Q4 2023 was $515.03K, a 18.29% increase from the previous quarter (Q3 2023), and a -64.07% decrease year-over-year (Q4 2022).
What is Ensysce Biosciences’s revenue growth rate?
Ensysce Biosciences's revenue growth rate for the last 3 years (2021-2023) was -36.83%, and for the last 5 years (2019-2023) was 26.45%.